GUIDED THERAPEUTICS INC (GTHP)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Sales - devices and disposables | 117 | - | - | - |
| Cost of goods sold | 38 | - | - | - |
| Gross profit | 79 | - | - | - |
| Sales and marketing | 51 | 73 | 76 | 69 |
| Research and development | 133 | 74 | 111 | 222 |
| General and administrative | 658 | 267 | 374 | 364 |
| Total operating expenses | 842 | 414 | 561 | 655 |
| Loss from operations | -763 | -414 | -561 | -655 |
| Other income (expenses) | - | - | - | 12 |
| Gain / (loss) from extinguishment of debt | - | -16 | - | - |
| Change in fair value of derivative liability | - | 52 | -1 | -7 |
| Other income | 64 | 98 | - | - |
| Interest income | - | - | - | - |
| Interest expense | 157 | 147 | 108 | 75 |
| Loss from extinguishment of debt | - | - | 16 | 16 |
| Change in fair value of derivative liability | 30 | - | - | - |
| Gain from forgiveness of debt | 15 | - | - | - |
| Total other income (expense) | -48 | -13 | -93 | -54 |
| Loss before income taxes | -811 | -427 | -654 | -709 |
| Provision for income taxes | - | - | - | - |
| Net loss | -811 | - | -654 | -709 |
| Preferred stock dividends | 45 | 36 | 38 | 49 |
| Net loss | - | -427 | - | - |
| Net loss attributable to common stockholders | -856 | -463 | -692 | -758 |
| Basic average shares | - | - | 57,039,000 | - |
| Basic | -0.01 | -0.01 | -0.01 | -0.01 |
| Diluted | -0.01 | -0.01 | -0.01 | -0.01 |
| Diluted | 78,838,000 | 68,291,000 | 57,039,000 | 55,986,000 |